Your browser doesn't support javascript.
loading
Androgen replacement therapy improves psychological distress and health-related quality of life in late onset hypogonadism patients in Chinese population / 中华医学杂志(英文版)
Chin. med. j ; Chin. med. j;(24): 3806-3810, 2012.
Article de En | WPRIM | ID: wpr-256638
Bibliothèque responsable: WPRO
ABSTRACT
<p><b>BACKGROUND</b>Late onset hypogonadism negatively impacts on men's psychological well-being. This study was conducted to examine the interrelationship among symptoms of testosterone deficiency, psychological well-being, and quality of life.</p><p><b>METHODS</b>Eligible subjects were randomized into active treatment and control groups, and were asked to complete the following questionnaires at baseline and month 6: aging male's symptoms (AMS) rating scale, hospital anxiety and depression scale (HADS), perceived stress scale (PSS) and the short form health survey-12 (SF-12). In this study, men were treated and monitored for 6 months with oral testosterone undecanoate (TU) capsules or vitamin E/C capsules in a single-blinded fashion. All in the active treatment group were administered a total of 120 - 160 mg TU orally on a daily basis. Total and free T levels between baseline and month 6 were compared.</p><p><b>RESULTS</b>One hundred and sixty eligible subjects were recruited and followed up. In the active treatment group, total serum testosterone concentrations before and after intervention were (7.98 ± 0.73) nmol/L and (13.7 ± 1.18) nmol/L. The mean HADS anxiety subscale scores for the subjects at baseline and at month 6 were 3.47 ± 0.4 and 1.72 ± 0.2, respectively (t = 1.526, P < 0.05). Additionally, the mean HADS depression subscale scores were 4.91 ± 0.6 and 2.39 ± 0.3, respectively (t = 3.466, P < 0.05). The mean scores on PSS for the subjects at baseline and at month 6 were 12.88 ± 2.1 and 9.83 ± 1.7, respectively (t = 4.009, P < 0.05). Significantly improved SF-12 could be observed (t = 1.433 and 1.118, respectively; both P < 0.05). No significant changes were observed in the control group at month 6.</p><p><b>CONCLUSION</b>Androgen replacement not only improves androgen deficiency associated symptoms, but also enhances comprehensive improvement in psychological issues.</p>
Sujet(s)
Texte intégral: 1 Indice: WPRIM Sujet Principal: Anxiété / Psychologie / Qualité de vie / Testostérone / Sang / Méthode en simple aveugle / Âge de début / Hormonothérapie substitutive / Utilisations thérapeutiques / Dépression Type d'étude: Clinical_trials Limites du sujet: Aged / Humans / Male langue: En Texte intégral: Chin. med. j Année: 2012 Type: Article
Texte intégral: 1 Indice: WPRIM Sujet Principal: Anxiété / Psychologie / Qualité de vie / Testostérone / Sang / Méthode en simple aveugle / Âge de début / Hormonothérapie substitutive / Utilisations thérapeutiques / Dépression Type d'étude: Clinical_trials Limites du sujet: Aged / Humans / Male langue: En Texte intégral: Chin. med. j Année: 2012 Type: Article